Showing 19,461 - 19,480 results of 29,412 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 19461

    Image 1_Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells.jpg by Donatella Treppiedi (10146335)

    Published 2025
    “…Interestingly, cells incubation with the recombinant VEGF164a protein impaired the decrease of cell migration and cell viability mediated by both SRPK1 inhibitors. …”
  2. 19462

    Table_2_Development of bacteria-based bioorganic phosphate fertilizer enriched with rock phosphate for sustainable wheat production.DOCX by Zoya Aslam (19196917)

    Published 2024
    “…Five isolates were the efficient phosphate solubilizers based on in vitro phosphate-solubilizing activity (291–454 μg ml<sup>−1</sup> and 278–421 μg ml<sup>−1</sup>) with a concomitant decrease in pH (up to 4.5) at 45°C and 50°C, respectively. …”
  3. 19463

    Effect of T/HS without or with IL-6 treatment on the liver inflammation transcriptome; impact of Stat3 inhibition on the IL-6 effect. by Ana Moran (80716)

    Published 2011
    “…In <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0021449#pone-0021449-g004" target="_blank">Figure 4B</a>, the 235 inflammation transcriptome genes whose expression levels were changed in SBR50 vs. sham were separated into those genes whose transcript levels were increased in SBR50 vs. sham (126 genes; left side of panel) and those whose transcript levels were decreased in SBR50 vs. sham (109 genes; right side of the panel). …”
  4. 19464

    Junctional Adhesion Molecules (JAMs) - New Players in Breast Cancer? by Gozie Offiah (7897577)

    Published 2022
    “…This serves to underline the fact that malignant transformation in a heterogeneous disease like breast cancer is a dynamic process evolving through multiple multi-step pathway models.</p> <p> </p><p> </p><p>Many factors are thought to be responsible for the development of breast cancer. …”
  5. 19465

    Experimental protocol of extracellular stimulations. by Sébastien Joucla (312219)

    Published 2013
    “…In order to perform all trials in the same conditions, a slow holding current (time constant: 5 s) was injected to maintain <i>V<sub>m</sub></i> at a corrected value of about −69 mV. …”
  6. 19466

    Synthesis and Activity of Ruthenium Olefin Metathesis Catalysts Coordinated with Thiazol-2-ylidene Ligands by Georgios C. Vougioukalakis (2290621)

    Published 2008
    “…Upon removing the steric bulk from the <i>ortho</i> positions of the <i>N</i>-aryl group of the thiazole-2-ylidene ligands, the phosphine-free catalysts lose stability, but when the substituents become too bulky the resulting catalysts show prolonged induction periods. Among five thiazole-2-ylidene ligands examined, 3-(2,4,6-trimethylphenyl)- and 3-(2,6-diethylphenyl)-4,5-dimethylthiazol-2-ylidene afforded the most efficient and stable catalysts. …”
  7. 19467

    Fabrication of Mouse Embryonic Stem Cell-Derived Layered Cardiac Cell Sheets Using a Bioreactor Culture System by Katsuhisa Matsuura (111393)

    Published 2012
    “…After a further 8 days of cultivation together with a purification step, around 1×10<sup>8</sup> cardiomyocytes were collected in a 1-L bioreactor culture, and additional treatment with noggin and granulocyte colony stimulating factor increased the number of cardiomyocytes to around 5.5×10<sup>8</sup>. …”
  8. 19468

    Table 3_Do the diagnosis-related group payment reforms have a negative impact?—an empirical study from Western China.docx by Jia-Yi Wang (490704)

    Published 2025
    “…</p>Results<p>The DRG reform reduced hospitalization costs, diagnostic costs, drug costs, and nursing costs by 6.5, 4.2, 7.9, and 26.2%, respectively, in the treatment group hospitals (p < 0.01), but increased the hospitalization times by 17.5% (p < 0.01); there was a “reimbursement bias” for patients with different types of medical insurance. …”
  9. 19469

    Table 2_Do the diagnosis-related group payment reforms have a negative impact?—an empirical study from Western China.xlsx by Jia-Yi Wang (490704)

    Published 2025
    “…</p>Results<p>The DRG reform reduced hospitalization costs, diagnostic costs, drug costs, and nursing costs by 6.5, 4.2, 7.9, and 26.2%, respectively, in the treatment group hospitals (p < 0.01), but increased the hospitalization times by 17.5% (p < 0.01); there was a “reimbursement bias” for patients with different types of medical insurance. …”
  10. 19470

    Synthesis and Activity of Ruthenium Olefin Metathesis Catalysts Coordinated with Thiazol-2-ylidene Ligands by Georgios C. Vougioukalakis (2290621)

    Published 2008
    “…Upon removing the steric bulk from the <i>ortho</i> positions of the <i>N</i>-aryl group of the thiazole-2-ylidene ligands, the phosphine-free catalysts lose stability, but when the substituents become too bulky the resulting catalysts show prolonged induction periods. Among five thiazole-2-ylidene ligands examined, 3-(2,4,6-trimethylphenyl)- and 3-(2,6-diethylphenyl)-4,5-dimethylthiazol-2-ylidene afforded the most efficient and stable catalysts. …”
  11. 19471

    Supplementary Material for: Public attitudes towards the DEA’s proposal to reschedule marijuana: a cross-sectional mixed methods analysis by figshare admin karger (2628495)

    Published 2025
    “…Comments from the proposal were stratified according to the submission date as early (5-21-6/11), mid (6/12-7/2), and late (7/3-7/22) respondents. …”
  12. 19472

    Computational modeling results. by Jaejoong Kim (11668928)

    Published 2024
    “…</b> In the escaping behavior, compared to the hunting behavior, <i>θ</i>, the time step of computation was shorter (Escape vs. Hunt: 10.9 vs. 15.6 in experiment 1; 11.4 vs. 15.5 in experiment 2; all <i>p</i> < 0.001 in mixed-effect regression) and the <i>τ</i> was lower (Escape vs. …”
  13. 19473

    Synthesis and Activity of Ruthenium Olefin Metathesis Catalysts Coordinated with Thiazol-2-ylidene Ligands by Georgios C. Vougioukalakis (2290621)

    Published 2008
    “…Upon removing the steric bulk from the <i>ortho</i> positions of the <i>N</i>-aryl group of the thiazole-2-ylidene ligands, the phosphine-free catalysts lose stability, but when the substituents become too bulky the resulting catalysts show prolonged induction periods. Among five thiazole-2-ylidene ligands examined, 3-(2,4,6-trimethylphenyl)- and 3-(2,6-diethylphenyl)-4,5-dimethylthiazol-2-ylidene afforded the most efficient and stable catalysts. …”
  14. 19474

    Table 1_Do the diagnosis-related group payment reforms have a negative impact?—an empirical study from Western China.xlsx by Jia-Yi Wang (490704)

    Published 2025
    “…</p>Results<p>The DRG reform reduced hospitalization costs, diagnostic costs, drug costs, and nursing costs by 6.5, 4.2, 7.9, and 26.2%, respectively, in the treatment group hospitals (p < 0.01), but increased the hospitalization times by 17.5% (p < 0.01); there was a “reimbursement bias” for patients with different types of medical insurance. …”
  15. 19475

    Synthesis and Activity of Ruthenium Olefin Metathesis Catalysts Coordinated with Thiazol-2-ylidene Ligands by Georgios C. Vougioukalakis (2290621)

    Published 2008
    “…Upon removing the steric bulk from the <i>ortho</i> positions of the <i>N</i>-aryl group of the thiazole-2-ylidene ligands, the phosphine-free catalysts lose stability, but when the substituents become too bulky the resulting catalysts show prolonged induction periods. Among five thiazole-2-ylidene ligands examined, 3-(2,4,6-trimethylphenyl)- and 3-(2,6-diethylphenyl)-4,5-dimethylthiazol-2-ylidene afforded the most efficient and stable catalysts. …”
  16. 19476

    Representative Staining of Peripheral Blood during immunosuppression by cyclophosphamide. by Andrew S. Wagner (11331477)

    Published 2021
    “…Erythrocytes were lysed using 2 ACK lysis steps (ref), cells were counted and stained using myeloid markers (α-Ly6C: HK1.4, APC, BioLegend) (α-Ly6G: 1A8, PerCP-Cy5.5, BioLegend) (α-CD11b: M1/70 clone, BV421, BioLegend) (α-F4/80: BM8, PE, BioLegend) (Fixable NIR Live-Dead: APC-Cy7, Invitrogen; cat #:L34975). …”
  17. 19477

    Data_Sheet_1_Future Representation of Species’ Climatic Niches in Protected Areas: A Case Study With Austrian Endemics.CSV by Philipp Semenchuk (11497633)

    Published 2021
    “…We found that under both a medium (RCP 4.5) and severe (RCP 8.5) climate change scenario, representation of endemic species’ climatic niches by PAs will decrease to a sixth for animals and to a third for plants, on average, toward the end of the century. …”
  18. 19478

    Data_Sheet_1_Future Representation of Species’ Climatic Niches in Protected Areas: A Case Study With Austrian Endemics.docx by Philipp Semenchuk (11497633)

    Published 2021
    “…We found that under both a medium (RCP 4.5) and severe (RCP 8.5) climate change scenario, representation of endemic species’ climatic niches by PAs will decrease to a sixth for animals and to a third for plants, on average, toward the end of the century. …”
  19. 19479

    Probing the auditory nerve using round-window response in control and ouabain-poisoned cochleae. by Charlène Batrel (3639406)

    Published 2017
    “…The frequency probe varied from 1 to 32 kHz in 1/3 octave steps and sound level from 10 (red curve) to 60 dB SPL (green curve) in 10 dB steps. …”
  20. 19480